Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Veracyte Inc (VCYT)

Veracyte Inc (VCYT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,181,598
  • Shares Outstanding, K 48,446
  • Annual Sales, $ 92,010 K
  • Annual Income, $ -23,000 K
  • 60-Month Beta 0.97
  • Price/Sales 13.43
  • Price/Cash Flow N/A
  • Price/Book 5.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.07
  • Number of Estimates 3
  • High Estimate -0.04
  • Low Estimate -0.12
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +41.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.60 +16.71%
on 10/03/19
26.65 -5.40%
on 09/23/19
-0.96 (-3.67%)
since 09/17/19
3-Month
21.60 +16.71%
on 10/03/19
31.18 -19.15%
on 07/22/19
-3.81 (-13.13%)
since 07/17/19
52-Week
9.20 +174.02%
on 10/26/18
31.18 -19.15%
on 07/22/19
+14.29 (+130.86%)
since 10/17/18

Most Recent Stories

More News
Look for Shares of Veracyte Inc to Potentially Rebound after Yesterday's 1.92% Sell Off

Veracyte Inc (NASDAQ:VCYT) traded in a range yesterday that spanned from a low of $24.48 to a high of $25.69. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $24.59...

VCYT : 25.16 (+3.16%)
Shares of Pfenex Inc Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (PFNX, VCYT , KPTI , GBT , REGN )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

KPTI : 10.74 (+2.68%)
VCYT : 25.16 (+3.16%)
PFNX : 8.84 (+1.84%)
Veracyte Inc Rises 4.08% on Heavy Volume: Watch For Potential Pullback

Veracyte Inc (NASDAQ:VCYT) traded in a range yesterday that spanned from a low of $23.30 to a high of $24.30. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $23.89...

VCYT : 25.16 (+3.16%)
Veracyte to Release Third Quarter 2019 Financial Results and Business Progress on October 22, 2019

Veracyte, Inc. (Nasdaq: VCYT) today announced that it will release its financial results for the third quarter 2019 and business progress after the close of market on Tuesday, October 22, 2019. Company...

VCYT : 25.16 (+3.16%)
Veracyte to Announce New Clinical Data for First Noninvasive Nasal Swab Test to Target Early Lung Cancer Detection at CHEST Annual Meeting 2019

Veracyte, Inc. (Nasdaq: VCYT) today announced that preliminary clinical data for the company's noninvasive nasal swab test - the first of its kind - for early detection of lung cancer will be presented...

VCYT : 25.16 (+3.16%)
After Yesterday's Decline of 1.02%, Veracyte Inc Offers Investors Better Value

Veracyte Inc (NASDAQ:VCYT) traded in a range yesterday that spanned from a low of $23.68 to a high of $24.56. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $24.43...

VCYT : 25.16 (+3.16%)
Personalis Appoints Karin Eastham to Its Board of Directors

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that it has appointed Karin Eastham as an independent director to its Board of Directors. Ms. Eastham brings more...

ILMN : 311.48 (+0.58%)
MOR : 27.59 (+0.40%)
VCYT : 25.16 (+3.16%)
PSNL : 11.96 (-0.50%)
Veracyte Announces Publication of Clinical and Analytical Validation Data for Afirma Xpression Atlas

Veracyte, Inc. (Nasdaq: VCYT) today announced the publication of new data demonstrating the clinical and analytical validity of its Afirma(R) Xpression Atlas (XA) genomic test, which is used to help guide...

VCYT : 25.16 (+3.16%)
Veracyte Announces Publication of New Study Characterizing Gene Alterations in Thyroid Cancer

Veracyte, Inc. (Nasdaq: VCYT) today announced the publication of new data that further define the genomic landscape around thyroid cancer. The study findings help characterize the role of specific gene...

VCYT : 25.16 (+3.16%)
Veracyte to Present at Upcoming Investor Conferences

Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, chairman and chief executive officer, will present at the following upcoming investor conferences:

MS : 43.69 (+2.10%)
WFC : 49.77 (+0.36%)
VCYT : 25.16 (+3.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade VCYT with:

Business Summary

Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also...

See More

Key Turning Points

2nd Resistance Point 26.26
1st Resistance Point 25.33
Last Price 25.16
1st Support Level 23.82
2nd Support Level 23.24

See More

52-Week High 31.18
Last Price 25.16
Fibonacci 61.8% 22.78
Fibonacci 50% 20.19
Fibonacci 38.2% 17.60
52-Week Low 9.20

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar